Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus membranaceus extract (Astragaloside IV) in diabetic nephropathy
TCTR20200305003Phase 2Not yet recruiting
- Sponsor
- FAME Pharmaceuticals
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 2 trial in diabetic glomerulosclerosis, sponsored by FAME Pharmaceuticals. Primary endpoints: Renal function and Proteinuria. Planned start Apr 2020; status: not yet recruiting.
02
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on TCTR20200305003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200305003.